A Phase 1, Placebo-controlled, Single-Ascending-Dose, Study of BIOPIN 6 in Healthy Adults
The purpose of this study is to evaluate the safety and blood levels of a medicine, naltrexone, contained within an implant in healthy volunteers age 18 to 65 years. To do this, the implant containing the drug will be inserted under the skin, left in place for 3 months and then removed.
100 Clinical Results associated with Drug Delivery Co. LLC
0 Patents (Medical) associated with Drug Delivery Co. LLC
100 Deals associated with Drug Delivery Co. LLC
100 Translational Medicine associated with Drug Delivery Co. LLC